This finding—in addition to concerns over the sensitivity of progesterone measurements in early studies, as well as studies demonstrating paracrine effects of progesterone via neighboring PR-positive cells [42]—warrants future studies including mediation analyses to determine what dictates the effect of progesterone on postmenopausal ER-positive breast cancer. This evidence concerns the gene PGR and breast carcinoma.